3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年3月31日)
|
当連結会計年度
(2025年3月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
27,282
|
26,727
|
|
|
|
受取手形、売掛金及び契約資産
|
16,909
|
21,377
|
|
|
|
商品及び製品
|
4,697
|
4,505
|
|
|
|
仕掛品
|
129
|
211
|
|
|
|
原材料及び貯蔵品
|
343
|
4,162
|
|
|
|
その他
|
3,329
|
3,366
|
|
|
|
貸倒引当金
|
△2
|
△3
|
|
|
|
流動資産合計
|
52,690
|
60,348
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物(純額)
|
6,971
|
8,749
|
|
|
|
|
工具、器具及び備品(純額)
|
1,448
|
1,693
|
|
|
|
|
土地
|
6,925
|
6,943
|
|
|
|
|
その他(純額)
|
936
|
754
|
|
|
|
|
有形固定資産合計
|
16,281
|
18,141
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
32,133
|
39,395
|
|
|
|
|
営業権
|
-
|
29,366
|
|
|
|
|
ソフトウエア
|
798
|
1,027
|
|
|
|
|
その他
|
204
|
549
|
|
|
|
|
無形固定資産合計
|
33,136
|
70,338
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
132
|
143
|
|
|
|
|
関係会社株式
|
7,714
|
-
|
|
|
|
|
敷金及び保証金
|
4,061
|
4,174
|
|
|
|
|
繰延税金資産
|
2,164
|
2,418
|
|
|
|
|
退職給付に係る資産
|
-
|
2,136
|
|
|
|
|
その他
|
1,618
|
1,990
|
|
|
|
|
貸倒引当金
|
△21
|
△21
|
|
|
|
|
投資その他の資産合計
|
15,670
|
10,841
|
|
|
|
固定資産合計
|
65,089
|
99,321
|
|
|
資産合計
|
117,779
|
159,669
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:百万円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2024年3月31日)
|
当連結会計年度
(2025年3月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
買掛金
|
22,098
|
30,715
|
|
|
|
短期借入金
|
-
|
13,500
|
|
|
|
1年内返済予定の長期借入金
|
8,155
|
8,369
|
|
|
|
未払金
|
1,520
|
5,149
|
|
|
|
未払法人税等
|
2,197
|
2,761
|
|
|
|
賞与引当金
|
2,436
|
2,436
|
|
|
|
返金負債
|
-
|
7,082
|
|
|
|
その他
|
2,414
|
4,187
|
|
|
|
流動負債合計
|
38,823
|
74,202
|
|
|
固定負債
|
|
|
|
|
|
長期借入金
|
23,477
|
19,202
|
|
|
|
繰延税金負債
|
302
|
302
|
|
|
|
役員退職慰労引当金
|
31
|
156
|
|
|
|
退職給付に係る負債
|
859
|
885
|
|
|
|
資産除去債務
|
1,093
|
1,175
|
|
|
|
その他
|
353
|
1,605
|
|
|
|
固定負債合計
|
26,118
|
23,328
|
|
|
負債合計
|
64,941
|
97,531
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
5,786
|
5,786
|
|
|
|
資本剰余金
|
11,276
|
11,301
|
|
|
|
利益剰余金
|
38,030
|
41,988
|
|
|
|
自己株式
|
△2,303
|
△1,959
|
|
|
|
株主資本合計
|
52,790
|
57,116
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
△0
|
6
|
|
|
|
その他の包括利益累計額合計
|
△0
|
6
|
|
|
非支配株主持分
|
48
|
5,014
|
|
|
純資産合計
|
52,837
|
62,138
|
|
負債純資産合計
|
117,779
|
159,669
|
E03476
30340
クオールホールディングス株式会社
Qol Holdings Co., Ltd.
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2024-04-01
2025-03-31
FY
2025-03-31
2023-04-01
2024-03-31
2024-03-31
1
false
false
false
30340
2025-05-09
30340
2024-04-01
2025-03-31
30340
2024-04-01
2025-03-31
jppfs_cor:CapitalStockMember
30340
2024-04-01
2025-03-31
jppfs_cor:CapitalSurplusMember
30340
2024-04-01
2025-03-31
jppfs_cor:NonControllingInterestsMember
30340
2024-04-01
2025-03-31
jpcrp_cor:ReconcilingItemsMember
30340
2024-04-01
2025-03-31
jpcrp_cor:ReportableSegmentsMember
30340
2024-04-01
2025-03-31
jppfs_cor:RetainedEarningsMember
30340
2024-04-01
2025-03-31
jppfs_cor:ShareholdersEquityMember
30340
2024-04-01
2025-03-31
jppfs_cor:TreasuryStockMember
30340
2024-04-01
2025-03-31
tse-acedjpfr-30340:BPOReportableSegmentsMember
30340
2024-04-01
2025-03-31
tse-acedjpfr-30340:HealthInsurancePharmacyReportableSegmentsMember
30340
2024-04-01
2025-03-31
tse-acedjpfr-30340:PharmaceuticalBusinessReportableSegmentMember
30340
2024-04-01
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
30340
2024-04-01
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
30340
2024-04-01
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
30340
2025-03-31
30340
2025-03-31
jppfs_cor:CapitalStockMember
30340
2025-03-31
jppfs_cor:CapitalSurplusMember
30340
2025-03-31
jppfs_cor:NonControllingInterestsMember
30340
2025-03-31
jpcrp_cor:ReconcilingItemsMember
30340
2025-03-31
jpcrp_cor:ReportableSegmentsMember
30340
2025-03-31
jppfs_cor:RetainedEarningsMember
30340
2025-03-31
jppfs_cor:ShareholdersEquityMember
30340
2025-03-31
jppfs_cor:TreasuryStockMember
30340
2025-03-31
tse-acedjpfr-30340:BPOReportableSegmentsMember
30340
2025-03-31
tse-acedjpfr-30340:HealthInsurancePharmacyReportableSegmentsMember
30340
2025-03-31
tse-acedjpfr-30340:PharmaceuticalBusinessReportableSegmentMember
30340
2025-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
30340
2025-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
30340
2025-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
30340
2023-04-01
2024-03-31
30340
2023-04-01
2024-03-31
jppfs_cor:CapitalStockMember
30340
2023-04-01
2024-03-31
jppfs_cor:CapitalSurplusMember
30340
2023-04-01
2024-03-31
jppfs_cor:NonControllingInterestsMember
30340
2023-04-01
2024-03-31
jpcrp_cor:ReconcilingItemsMember
30340
2023-04-01
2024-03-31
jpcrp_cor:ReportableSegmentsMember
30340
2023-04-01
2024-03-31
jppfs_cor:RetainedEarningsMember
30340
2023-04-01
2024-03-31
jppfs_cor:ShareholdersEquityMember
30340
2023-04-01
2024-03-31
jppfs_cor:TreasuryStockMember
30340
2023-04-01
2024-03-31
tse-acedjpfr-30340:BPOReportableSegmentsMember
30340
2023-04-01
2024-03-31
tse-acedjpfr-30340:HealthInsurancePharmacyReportableSegmentsMember
30340
2023-04-01
2024-03-31
tse-acedjpfr-30340:PharmaceuticalBusinessReportableSegmentMember
30340
2023-04-01
2024-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
30340
2023-04-01
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
30340
2023-04-01
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
30340
2024-03-31
30340
2024-03-31
jppfs_cor:CapitalStockMember
30340
2024-03-31
jppfs_cor:CapitalSurplusMember
30340
2024-03-31
jppfs_cor:NonControllingInterestsMember
30340
2024-03-31
jpcrp_cor:ReconcilingItemsMember
30340
2024-03-31
jpcrp_cor:ReportableSegmentsMember
30340
2024-03-31
jppfs_cor:RetainedEarningsMember
30340
2024-03-31
jppfs_cor:ShareholdersEquityMember
30340
2024-03-31
jppfs_cor:TreasuryStockMember
30340
2024-03-31
tse-acedjpfr-30340:BPOReportableSegmentsMember
30340
2024-03-31
tse-acedjpfr-30340:HealthInsurancePharmacyReportableSegmentsMember
30340
2024-03-31
tse-acedjpfr-30340:PharmaceuticalBusinessReportableSegmentMember
30340
2024-03-31
jpcrp_cor:UnallocatedAmountsAndEliminationMember
30340
2024-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
30340
2024-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
30340
2023-03-31
30340
2023-03-31
jppfs_cor:CapitalStockMember
30340
2023-03-31
jppfs_cor:CapitalSurplusMember
30340
2023-03-31
jppfs_cor:NonControllingInterestsMember
30340
2023-03-31
jppfs_cor:RetainedEarningsMember
30340
2023-03-31
jppfs_cor:ShareholdersEquityMember
30340
2023-03-31
jppfs_cor:TreasuryStockMember
30340
2023-03-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
30340
2023-03-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure